Therapeutics Acquisition Corp. (RACA) Research

Therapeutics Acquisition Corp., which operates as Research Alliance Corp. I, was founded in 2020 and is headquartered in Boston, Massachusetts. Its core mission is to pursue a business combination, including but not limited to mergers, capital stock exchanges, asset acquisitions, share purchases, or reorganizations, with one or more enterprises in the United States healthcare sector.

Market snapshot

Symbol
RACA
Price
$10.27
Day change
+2.44%
Market cap
$1.1B
52-week range
10-10.33
Sector
Financial Services
Industry
Shell Companies

Peer companies

  • Amplitude Healthcare Acquisition Corporation (AMHC)
  • Social Capital Suvretta Holdings Corp. I (DNAA)
  • FG New America Acquisition Corp. (FGNA)
  • FTAC Hera Acquisition Corp. (HERA)
  • Humacyte, Inc. (HUMA)
  • LifeSci Acquisition II Corp. (LSAQ)
  • TPG Pace Tech Opportunities Corp. (PACE)
  • Trebia Acquisition Corp. (TREB)

Recent insider activity

  • Kolchinsky Peter — A-Award (209100 shares) on 2021-06-29
  • RA CAPITAL MANAGEMENT, L.P. — P-Purchase (209100 shares) on 2021-06-29
  • Kolchinsky Peter — A-Award (889218 shares) on 2021-06-24
  • RA CAPITAL MANAGEMENT, L.P. — trade (0 shares) on 2021-06-23

Open Therapeutics Acquisition Corp. (RACA) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.